The acquisition of GeneWorks' oligo business widens IDT's reach in the Asia-Pacific region, the company said.
CareDx's CareDx Pty subsidiary said it will pay up to $735,000 to Conexio as a percentage of revenues from products acquired in the deal.
In addition to variant detection technology, Omicia also gets technologies like data compression, which will aid diagnostics development and data storage.
The deal, completed this month with cash reserves for an undisclosed price, adds scalability and multi-omics analysis to Qiagen's bioinformatics portfolio.
Identigene sells in-home DNA paternity test collection kits, while DNA Diagnostics conducts DNA testing for various applications, such as paternity and forensics.
Thermo Fisher said the deal strengthens its portfolio for stem cell research, and it will fold MTI-GlobalStem into its life sciences solutions segment.
The company purchased Tute in a stock-based transaction that closed last month.
The diagnostics provider said it has paid $250,000 for assets comprised of promissory notes, Series A and Series B stock, and intellectual property.
The deal marks the first software-related acquisition for Agilent since the firm acquired Cartagenia last year.
The acquisition of San Diego-based ValueGene expands IDT's presence in Southern California.
A Karmagenes researcher has lost his position after reportedly admitting to data fabrication, according to Retraction Watch.
Two neuroscientists write in Nature News that solving the "reproducibility crisis" in science may require changing the requirements for publication.
In Nature this week: genomic analysis of prehistoric New Mexicans, a nanopore method for mapping DNA methylation, and more.
A new study finds that adding missing good bacteria to the skin microbiome of atopic dermatitis patients decreases Staphylococcus aureus colonization.